D. E. Shaw & Co., Inc. Zentalis Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,239,459 shares of ZNTL stock, worth $2.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,239,459

Previous 1,128,577 9.82%

Holding current value

$2.22 Million

Previous $4.14 Million 9.32%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.7 - $4.03 $299,381 - $446,854	110,882 Added 9.82%	1,239,459 $3.76 Million
Q3 2024 Nov 14, 2024	BUY	$2.9 - $4.57 $2.58 Million - $4.06 Million	888,236 Added 369.57%	1,128,577 $4.14 Million
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $924,544 - $3.65 Million	226,050 Added 1581.76%	240,341 $982,000
Q1 2024 May 15, 2024	BUY	$10.83 - $16.49 $154,771 - $235,658	14,291 New	14,291 $225,000
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $734,927 - $1.06 Million	37,439 New	37,439 $751,000
Q3 2022 Nov 14, 2022	SELL	$20.23 - $31.73 $518,555 - $813,335	-25,633 Reduced 46.82%	29,112 $631,000
Q2 2022 Aug 15, 2022	BUY	$17.91 - $52.25 $605,107 - $1.77 Million	33,786 Added 161.2%	54,745 $1.54 Million
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $119,209 - $231,911	2,867 Added 15.85%	20,959 $967,000
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $2.43 Million - $3.08 Million	-36,346 Reduced 66.77%	18,092 $1.52 Million
Q3 2021 Nov 15, 2021	SELL	$46.83 - $73.5 $94,409 - $148,176	-2,016 Reduced 3.57%	54,438 $3.63 Million
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $1.28 Million - $2.13 Million	34,283 Added 154.63%	56,454 $3 Million
Q1 2021 May 17, 2021	SELL	$35.69 - $52.72 $825,010 - $1.22 Million	-23,116 Reduced 51.04%	22,171 $962,000
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $1.18 Million - $2.16 Million	37,294 Added 466.58%	45,287 $2.35 Million
Q3 2020 Nov 16, 2020	SELL	$27.03 - $47.97 $457,942 - $812,707	-16,942 Reduced 67.94%	7,993 $261,000
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $578,492 - $1.37 Million	24,935 New	24,935 $1.2 Million

Others Institutions Holding ZNTL

# of Institutions

147

Shares Held

65.3M

Call Options Held

43.2K

Put Options Held

21.7K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $102M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account